FOR IMMEDIATE RELEASE
January 24, 2017
For more information, contact
Glenn E. Martin at (520) 818-8582
WEED Inc. – The #1 Name, #1 Symbol and #1 Brand Throughout the Cannabis Industry Worldwide!
A World Class Cannabis Research Organization, Now Current PINK, Looks to RETURN Fully Reporting
TUCSON, AZ / ACCESSWIRE / January 24, 2017 / WEED, Inc. (BUDZ: OTC Pink) (the “Company” or “WEED”), fka United Mines, Inc., a current non-SEC reporting company, announces its goals for 2017. WEED intends to become a vertically integrated holding company in the “seed to sale” cannabis business through mergers, acquisitions, and joint ventures. (Once removed from Schedule 1 and Schedule II) WEED will work with its own contracted World Class respected master growers, botanists, and horticulturalists, some with decades of working knowledge with seed cultivation, cross breeding, genetic testing, pollination expertise, and cloning, to develop “WEED” exclusive cannabis seed banks and proprietary strains. WEED plans to conduct Cannabis Genomic studies in both Australia and the USA. WEED researchers will study cannabinoid-based therapies targeting a variety of different medical conditions and disorders through its consulting agreements with Ms. Karen Harland, WEED’s lead researcher and scientist in Australia, and Dr. Pat Williams of Sangre AgroTech Labs here in the United States.
The Company intends to return to fully reporting status with the Securities and Exchange Commission and to raise funds to support its activities. To date, no binding agreements have been executed with respect to any of the foregoing, other than the agreements with Ms. Harland and Dr. Williams.
WEEDs goals for 2017 include: Establish a research lab, propagation and cloning rooms in Colorado to support Cannabis DNA sequencing and testing, along with the purchase of Real Estate to secure WEEDs long term commitments in USA; Establish WEED LTD, an unlisted public company, in Australia, where Legal Cannabis became law October 30th. 2016, to begin strain specific, disease specific clinical trials.
“After 46 years of advocacy in this industry, it has been and will continue to be an honor to build the ‘American Dream’ on this new legal frontier with my daughter and co-Founder, Nicole Marie Breen, and her husband, Ryan Breen,” said WEED co-Founder and CEO Glenn E. Martin. “The CURES are out there. I am optimistic about WEED’s corporate strategy to become a World Leader in Cannabis research discoveries.”
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as “expects,” “anticipates,” “intends,” “estimates,” “plans,” “potential,” “possible,”
“probable,” “believes,” “seeks,” “may,” “will,” “should,” “could,” or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company’s business, including that we have a limited operating history and very limited funds, are dependent upon key personnel whose loss may adversely impact our business, some of our potential business activities, while believed to be compliant with applicable state law, may be illegal under federal law because they violate the Federal Controlled Substances Act, and we may be subject to the risks related to the cost, delays and uncertainties associated with potential future scientific research, product development, clinical trials and the regulatory approval process. We may not be able to enter into binding agreements related to the subject matter of this press release on terms favorable to us or at all. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.
Glenn E. Martin
Co-Founder and CEO
WEED Inc. (520) 818-8582
SOURCE: WEED Inc.